These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17120369)

  • 41. Rising standards for tuberculosis drug development.
    Balganesh TS; Alzari PM; Cole ST
    Trends Pharmacol Sci; 2008 Nov; 29(11):576-81. PubMed ID: 18799223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Determining drug resistance of the clinical strains of Mycobacterium tuberculosis to pyrazinamide].
    Nizova AV; Stepanshina VN; Maĭskaia NV; Mironova RI; Bogun AG; Domotenko LV; Morozova TP; Shemiakin IG
    Mol Gen Mikrobiol Virusol; 2008; (4):23-6. PubMed ID: 19172875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Southern Africa is moving swiftly to combat the threat of XDR-TB.
    Wise J
    Bull World Health Organ; 2006 Dec; 84(12):924-5. PubMed ID: 17242824
    [No Abstract]   [Full Text] [Related]  

  • 44. First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran.
    Tabarsi P; Chitsaz E; Moradi A; Baghaei P; Farnia P; Marjani M; Irannejad P; Mansouri D; Masjedi M
    Int J STD AIDS; 2009 Aug; 20(8):566-70. PubMed ID: 19625590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tuberculosis. Few mutations divide some drug-resistant TB strains.
    Koenig R
    Science; 2007 Nov; 318(5852):901-2. PubMed ID: 17991835
    [No Abstract]   [Full Text] [Related]  

  • 46. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
    Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
    Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug resistance of Mycobacterium tuberculosis in the Sunamganj District of Bangladesh.
    Storla DG; Rahim Z; Islam MA; Plettner S; Begum V; Myrvang B; Bjune G; Rønnild E; Dahle UR; Mannsåker T
    Scand J Infect Dis; 2007; 39(2):142-5. PubMed ID: 17366031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
    Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC
    J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Update - pathogens of concern.
    McFee RB
    Dis Mon; 2013 Dec; 59(12):437-8. PubMed ID: 24314806
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains].
    Chikamatsu K; Mizuno K; Yamada H; Mitarai S
    Kekkaku; 2009 Sep; 84(9):631-3. PubMed ID: 19860266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular snapshot of drug-resistant and drug-susceptible Mycobacterium tuberculosis strains circulating in Bulgaria.
    Valcheva V; Mokrousov I; Narvskaya O; Rastogi N; Markova N
    Infect Genet Evol; 2008 Sep; 8(5):657-63. PubMed ID: 18657631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug susceptibility pattern of Mycobacterium tuberculosis in adult patients with miliary tuberculosis.
    Irfan M; Hussain SF; Jabeen K; Islam M
    Trop Doct; 2007 Jul; 37(3):182-4. PubMed ID: 17716515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-tuberculosis drug resistance among new and previously treated pulmonary tuberculosis patients in Cotonou, Benin.
    Affolabi D; Adjagba OA; Tanimomo-Kledjo B; Gninafon M; Anagonou SY; Portaels F
    Int J Tuberc Lung Dis; 2007 Nov; 11(11):1221-4. PubMed ID: 17958985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug abuse profile - patient delay, diagnosis delay and drug resistance pattern - among addict patients with tuberculosis.
    Shamaei M; Marjani M; Baghaei P; Chitsaz E; Rezaei Tabar E; Abrishami Z; Tabarsi P; Mansouri D; Masjedi MR
    Int J STD AIDS; 2009 May; 20(5):320-3. PubMed ID: 19386968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New generation methods for drug susceptibility testing for tuberculosis.
    Katoch VM
    Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820
    [No Abstract]   [Full Text] [Related]  

  • 56. Emerging drugs for active tuberculosis.
    Ginsberg AM
    Semin Respir Crit Care Med; 2008 Oct; 29(5):552-9. PubMed ID: 18810688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Funding. Experts look for more to fight TB, HIV/AIDS coinfection.
    AIDS Policy Law; 2009 Sep; 24(10):3. PubMed ID: 19827208
    [No Abstract]   [Full Text] [Related]  

  • 58. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
    Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
    J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire).
    N'Guessan KR; Dosso M; Ekaza E; Kouakou J; Jarlier V
    Int J Antimicrob Agents; 2008 May; 31(5):498-500. PubMed ID: 18313272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.